Inaugural AL Amyloidosis Conference in Brussels 5th and 6th July 2024
We recently had the opportunity to attend the inaugural AL…
Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.
Join us in providing programs and activities to benefit the lives of amyloidosis community, and make sure the community’s needs are met by decision-makers
Make a positive impact
Our advocacyNetworks committed to the same causes
Our networksChange & save a life
Donate nowWe want to empower patients, families, and caregivers, as well as members of the ATTR medical community to advocate to federal, provincial and territorial governments on issues that are important to our community. Your engagement in advocacy can help ensure that the amyloidosis community’s voice is heard, and needs are met by decision-makers.
We collaborate with a network of organizations, businesses, and community leaders to expand resources, enhance services, and create sustainable solutions.
Your donation supports our programs and activities to benefit the lives of amyloidosis patients, their families and caregivers. We allocate those funds free from influence.
Please note: HAC is a not-for-profit organization – NOT a charitable organization. Please note that donations cannot be used for tax purposes.

hATTR amyloidosis is estimated to affect 50,000 people worldwide, with more than 130 different TTR gene mutations identified.

hATTR amyloidosis runs in families – A person only needs to inherit one copy of the affected gene from one parent in order to develop hATTR amyloidosis.

It can often take more than 4 years and visits with 5 or more doctors across different specialties to receive an accurate diagnosis of hATTR amyloidosis.

New therapies that address the underlying cause of hATTR amyloidosis are providing hope for people living with the disease.
Transthyretin amyloidosis (ATTR) is a complex condition caused by the misfolding of the transthyretin (TTR) protein. Normally, TTR transports thyroxine and retinol-binding protein, but genetic mutations or age-related changes cause it to form amyloid fibrils, leading to organ dysfunction.
Our goal is to provide those affected by ATTR with a digital patient checklist, empowering them to take control of their health. This checklist will help individuals identify potential symptoms, explore diagnostic tools available in Canada, and prepare for physician appointments. By doing so, we aim to support timely diagnosis and effective management of ATTR, improving the lives of those impacted by this condition.
We recently had the opportunity to attend the inaugural AL…
A report on treatments for hereditary transthyretin-related (hATTR) amyloidosis by…
Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic…
Reach out to us for support, collaborations, or to learn more about our programs.
TTR Amyloidosis Canada
98 David Street Hagersville, ON
N0A 1H0
Or visit the donation section
Let us know who you are and what you're looking for below, and we'll get back to you within 24 hours.